Australian REITS Stock News

In April 2026, APA Group completed a A$1.50 billion debt raise, including A$1.00 billion in hybrid subordinated capital securities and A$500 million in 6.42% senior unsecured notes due 2036, to support its stated growth plans. The strong investor demand for these fixed-income securities, with the issuances reportedly nearly four times oversubscribed, underlines fixed-income appetite for APA’s income-focused infrastructure profile. Now we’ll consider how this heavily oversubscribed A$1.50...

Suncorp Group Limited recently completed a Fixed-Income Offering, issuing A$200 million of Floating Rate Hybrid Notes that are convertible, non-cumulative and subordinated, with a variable coupon structure. This hybrid issuance adds a new layer to Suncorp’s capital structure, blending debt and equity characteristics that may influence how investors assess its funding mix and risk profile. We’ll now examine how Suncorp’s use of subordinated, floating rate hybrid capital could reshape its...

Recent share performance and fundamentals Greatland Resources (ASX:GGP) has drawn attention after a recent uptick in share price over the past month, alongside a year to date return above 25%, prompting investors to reassess the A$9.1b miner. The company reports revenue of A$1,918.1m and net income of A$645.1m, with revenue growth of 4.7% and net income movement showing a 5.0% decline on an annual basis. See our latest analysis for Greatland Resources. At a latest share price of A$13.5,...

Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...

In late April 2026, Telix Pharmaceuticals reported Phase 2 OPTIMAL-PSMA dosimetry data for its second-generation prostate cancer candidate TLX597-Tx, showing low radiation uptake in non-target organs and supporting further evaluation in earlier-stage disease, while also progressing a Regeneron collaboration and a European review of its glioma imaging agent TLX101-Px. These developments highlight how Telix is trying to build an integrated radiopharmaceutical platform, pairing next-generation...

With the business potentially at an important milestone, we thought we'd take a closer look at 6K Additive, Inc.'s...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Potential Tartana Minerals Limited ( ASX:TAT ) shareholders may wish to note that the Independent Non-Executive...

Cochlear Limited recently downgraded its FY26 net profit guidance from A$435–A$460 million to A$290–A$330 million, citing softer demand, delayed surgeries, and geopolitical disruptions in key markets. This setback has drawn attention to how dependent Cochlear’s earnings are on procedure volumes and hospital capacity, despite its strong competitive position in implantable hearing solutions. We’ll now examine how this earnings guidance cut, driven by weaker demand and delayed surgeries, may...

In late April 2026, Nickel Industries Limited reported its March quarter results, delivering record adjusted EBITDA of US$135.6 million, supported by a higher Indonesian production quota, accelerated ore sales, and progress on the Excelsior Nickel Cobalt project. Alongside this financial performance, the company highlighted a lost time injury frequency rate of 0.00, expanded conservation efforts over about 197 hectares of primary forest at Hengjaya, and a stronger liquidity position through...

This article walks step by step through whether BHP Group at around A$54.94 may be offering fair value, a stretch price, or a potential opportunity. The stock has seen a 4.5% return over the last 30 days and a 20.1% return year to date, while the 1 year return sits at 50.3% and the 5 year return at 73.5%, so recent price action is firmly on investors' radar. Recent coverage has focused on BHP Group's role as a major materials player, with attention on how global demand for resources and...

On 29 April 2026, Ramelius Resources reported its most profitable quarter to date, delivering a very large all-in sustaining cost margin despite revising cost guidance higher due partly to accounting changes and stronger gold prices. At the same time, the company accelerated its share buyback and advanced high‑grade discoveries at Dalgaranga, underlining management’s conviction in the business while industry‑wide diesel cost pressures continued to reshape its operating cost base. We’ll now...

Evolution Mining (ASX:EVN) has reported a significant uplift in its gold and copper resources, linked to recent exploration results and ongoing expansion studies. This has drawn fresh attention to the miner’s long term production profile. See our latest analysis for Evolution Mining. Despite the fresh resource update, Evolution Mining’s recent share price momentum has cooled, with a 30 day share price return of a 10.99% decline and a 90 day share price return of a 17.40% decline. This comes...

NEXTDC Limited recently completed a large-scale capital raising, including an A$750 million subordinated floating rate wholesale notes issue and an approximately A$1.51 billion rights-based follow-on equity offering, as part of its previously announced A$2.20 billion capital plan. These transactions lift NEXTDC’s pro forma liquidity to about A$6.60 billion and broaden its funding base as it pursues growth in Australia’s expanding data centre market. We’ll now examine how this expanded A$6.60...

BofA Securities has initiated coverage of Life360 (ASX:360). The firm highlights expectations for user growth, new offerings such as elderly and pet trackers, and deeper integration partnerships in the family safety app market. See our latest analysis for Life360. Life360’s A$20.0 share price comes after a year-to-date share price return decline of 38.39%, while the 3-year total shareholder return of about 3x suggests longer term holders have still seen very large gains. This may indicate...

Why Arafura Rare Earths’ Upcoming Earnings Call Matters Arafura Rare Earths (ASX:ARU) is set to hold its Q3 2026 earnings call on 29 April. Many investors are watching the event closely for fresh detail on project progress, funding, and outlook. See our latest analysis for Arafura Rare Earths. At a share price of A$0.36, Arafura Rare Earths has seen strong recent momentum, with a 30 day share price return of 18.03%, a 90 day share price return of 56.52%, and a 1 year total shareholder return...

Board refresh draws fresh attention to Aurelia Metals Aurelia Metals (ASX:AMI) has attracted fresh interest after announcing that Franklyn (Lyn) Brazil will rejoin its Board as a Non Executive Director, representing Brazil Farming Pty Ltd. Brazil brings prior Aurelia board experience, a background in agriculture and philanthropy, and a history of investing in ASX listed companies. Accounting and markets professional Bradley Newcombe will act as his alternate director. See our latest analysis...

South32 Limited recently reported its March 2026 quarter and year-to-date production, alongside confirming most FY26 production guidance but cutting Australia Manganese output guidance by 6% due to elevated site water levels and recent severe weather impacts. The company also scheduled a special call to update investors on its Hermosa project, underscoring the growing importance of this US growth asset within South32’s portfolio. We’ll now examine how the revised Australian Manganese...

Ora Banda Mining Ltd has appointed experienced mining executive John Richards as a non-executive director, effective 1 May 2026, with the board intending that he succeed outgoing chair Peter Mansell after the company’s 2026 annual general meeting in November. The leadership transition comes as Ora Banda reports strong operational performance, including high-grade gold intercepts at its Waihi project and record output from the Davyhurst gold operation, underscoring a period of operational...

ANZ Group Holdings (ASX:ANZ) has put fresh numbers on the table for H1 2026, with total revenue for the most recent half year at A$10.7 billion and basic EPS at A$0.76, set against trailing 12 month revenue of A$21.5 billion and EPS of A$1.98. Over recent halves, the bank has seen revenue move from A$10.1 billion in H2 2024 to A$11.0 billion in H1 2025 and A$10.7 billion in H2 2025, while basic EPS shifted from A$1.04 to A$1.23 and then A$0.76. This gives a clear view of how the top line and...

As global markets navigate a complex landscape marked by record highs in major U.S. stock indexes, driven by robust economic data and AI-linked stocks, small-cap companies are capturing investor interest amid resilient consumer demand and evolving geopolitical tensions. In this environment, identifying promising small-cap stocks involves considering factors such as strong earnings potential and strategic insider actions that align with broader market trends.

ASX (ASX:ASX) has just put two big pieces on the board at once, with CHESS Release 1 now live for clearing services and Darren Yip stepping in as Interim CEO during this infrastructure upgrade. See our latest analysis for ASX. The recent CHESS Release 1 go live and the leadership handover appear to have coincided with stronger interest in the stock, with a 1 month share price return of 16.25% and year to date share price return of 18.26%, set against a 1 year total shareholder return of...

Why the Q3 2026 earnings call matters for Lotus Resources The upcoming Q3 2026 earnings call for Lotus Resources (ASX:LOT) on 1 May puts fresh attention on the uranium explorer, as investors look for updated figures and commentary around its African project portfolio. See our latest analysis for Lotus Resources. Lotus Resources has seen heavy selling pressure, with a 1 day share price return of 34.04% and a 90 day share price return of 69.18%. The 1 year total shareholder return of 53.29%...

Why the new GlaxoSmithKline contract matters for 4DMedical 4DMedical (ASX:4DX) has drawn fresh attention after securing a one year engagement with GlaxoSmithKline to supply quantitative lung imaging analytics for pulmonary drug development and clinical research, in association with Flywheel Exchange. Under the agreement, starting May 1, 2026, 4DMedical will provide advanced lung imaging biomarkers from its software analytics platform, supporting sensitive, quantitative assessment of lung...